Glaxosmithkline Pharmaceuticals’ standalone net profit jumped 39.11% to Rs 181.65 crore in Q1 FY25 as compared to Rs 130.58 crore posted in Q1 FY24.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
Glaxosmithkline Pharmaceuticals’ standalone net profit jumped 39.11% to Rs 181.65 crore in Q1 FY25 as compared to Rs 130.58 crore posted in Q1 FY24.
| Subscribe To Our Free Newsletter |
